Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Pharma
Lilly to expand global GLP-1 access by 2040
The company's oral GLP-1, Fondayo, will be critical in the push for parity.
Donavyn Coffey
Sep 28, 2026 9:59am
The Oral GLP-1 Tracker: Scripts bounce back from holiday lull
Sep 25, 2026 2:00pm
Eli Lilly blasted for ‘emotive’ language in GLP-1 press release
Sep 25, 2026 9:01am
Novo is open to a direct listing on the New York Stock Exchange
Sep 23, 2026 11:28am
Lilly captures 70% of surging Medicare GLP-1 market, CEO says
Sep 23, 2026 10:55am
Novo CEO talks embracing change and staying bullish amid rebrand
Sep 17, 2026 8:45am
